Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 2000The Journal of Clinical Endocrinology & Metabolism

Skeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women1

View Full Paper
Ask AI
Bookmark
Share

Authors

RTRichard P. ToninoUniversity of RichmondPMPierre J. MeunierInstitut de la VisionRERonald EmkeyReading Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tonino et al. (2000) studied this question.

synapsesocial.com/papers/6a9953347e2600a00478cd09https://doi.org/10.1210/jcem.85.9.6777
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Differential Effects of Alendronate and Estrogen on the Rate of Bone Loss After Discontinuation of Treatment1999 · 9 citations
  2. 2Bisphosphonate Effects and the Bone Remodeling Transient1997 · 87 citations
  3. 3Suppressed Bone Turnover by Bisphosphonates Increases Microdamage Accumulation and Reduces Some Biomechanical Properties in Dog Rib2000 · 698 citations